Commentary – Pharma-Academic Partnerships: A Tangled Web of IP rights?
This article was originally published in Scrip
Executive Summary
A number of reports have recently emerged about large pharmaceutical companies looking beyond their own walls for scientific discoveries by partnering with academic institutions – and in new ways, significantly different from old style, traditional partnering arrangements.